- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pre-Exposure Prophylaxis of HIV-1 Infection in Germany
Total 69 results
-
Gilead SciencesActive, not recruitingPre-Exposure Prophylaxis of HIV-1 InfectionUnited States, Austria, Denmark, United Kingdom, Netherlands, Italy, Germany, Canada, Ireland, France, Spain
-
Gilead SciencesCompleted
-
Bionor Immuno ASCelgene CorporationCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedHIV-1 InfectionGermany, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Immune System Regulation ABUnknownHIV-1-infectionSweden, Germany
-
Radboud University Medical CenterTerminatedHIV-1 InfectionNetherlands, Germany
-
Bionor Immuno ASCompletedHIV-1 InfectionUnited States, Spain, Germany, Italy, United Kingdom
-
Christoph StephanUniversity Hospital HeidelbergCompleted
-
Goethe UniversityHIVCENTERUnknownCancer | Immunosuppression | HIV-1 InfectionGermany
-
PfizerViiV HealthcareCompleted
-
NEAT ID FoundationViiV HealthcareCompletedHIV-1-infectionSpain, Belgium, France, Germany, Italy, United Kingdom
-
Gilead SciencesCompletedHIV-1Austria, Germany, Italy, Spain
-
Gilead SciencesCompletedHIV-1 InfectionSpain, France, United States, Germany, Italy
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United Kingdom, France, Germany, United States, Italy
-
Euresist Network GEIEKarolinska Institutet; Pomeranian Medical University Szczecin; University Hospital... and other collaboratorsRecruitingHIV-1-infectionSweden, Germany, Italy, Poland
-
PfizerEuropean Society for Blood and Marrow TransplantationCompletedProphylaxis Of Invasive Fungal InfectionsPortugal, Belgium, France, Germany, Spain, United Kingdom, Switzerland, Sweden
-
Abbott BiologicalsCompletedProphylaxis of InfluenzaGermany
-
Janssen R&D IrelandCompletedHIV-1 InfectionUnited States, Australia, France, United Kingdom, China, Belgium, Germany, Spain, Argentina, Romania, South Africa, Canada, Denmark, Netherlands, Chile, Puerto Rico, Austria, Russian Federation, Thailand, Sweden, Taiwan
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United Kingdom, Sweden, Germany, United States, France, Belgium, Ireland, Italy, Denmark, Puerto Rico, Canada
-
Gilead SciencesCompletedHIV-1-infectionUnited States, Puerto Rico, France, Germany, Austria, Canada
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, Italy, Germany, United Kingdom, France, Australia, Puerto Rico, Canada, Belgium, Dominican Republic
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, Spain, United Kingdom, Canada, Puerto Rico, France, Belgium, Italy, Germany, Austria
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, Spain, United Kingdom, Netherlands, Germany, Canada, Sweden, Switzerland, Italy, Belgium, Puerto Rico, France
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, France, Italy, Germany, Canada, United Kingdom, Belgium, Puerto Rico, Australia
-
Gilead SciencesActive, not recruitingHIV-1-infectionUnited States, Spain, France, Taiwan, Japan, Thailand, Dominican Republic, Germany, Canada, Italy, South Africa
-
Gilead SciencesCompletedHIV-1 InfectionFrance, Spain, Germany, United Kingdom, United States, Puerto Rico, Belgium, Canada, Italy, Dominican Republic
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, France, Germany, United Kingdom, Italy, Canada, Australia, Belgium, Puerto Rico, Dominican Republic
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, United Kingdom, Switzerland, Germany, Canada, France, Belgium, Puerto Rico
-
Gilead SciencesCompletedHIV-1 InfectionCanada, United States, Puerto Rico, Spain, United Kingdom, France, Portugal, Netherlands, Belgium, Italy, Australia, Austria, Germany, Switzerland
-
GCS IHFB Cognacq-JayHospital Ambroise Paré ParisCompletedHIV-1-infection | HIV Associated Neurocognitive DisorderFrance
-
Rigshospitalet, DenmarkHorizon 2020 - European Commission; IrsiCaixaNot yet recruitingInflammation | HIV-1-infection | AIDSSpain, United Kingdom, Denmark, France, Israel, Germany, Belgium, Croatia, Czechia, Greece, Hungary, Italy, Luxembourg, Poland
-
Baxalta now part of ShireBaxter Innovations GmbHCompleted
-
GlaxoSmithKlineTerminatedHIV-1Australia, Belgium, Canada, France, Germany, Greece, Italy, Spain, United Kingdom
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, France, Austria, Germany
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedHuman Immunodeficiency Virus (HIV)-1 InfectionUnited States, Spain, Germany, Dominican Republic
-
PfizerTerminatedHIV-1Spain, United Kingdom, Malaysia, United States, Portugal, Brazil, Germany, Italy, Poland, Puerto Rico, South Africa, Taiwan, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingHIV-1 InfectionUnited States, Argentina, Canada, Chile, Colombia, France, Germany, Israel, Italy, Japan, South Africa, Spain, Taiwan
-
Tibotec Pharmaceuticals, IrelandCompletedHIV-1United States, Canada, France, Belgium, Germany, Spain, Argentina, Chile, Panama, Brazil, Puerto Rico, Thailand, Mexico, Australia
-
Merck Sharp & Dohme LLCCompletedHIV-1 InfectionUnited States, Australia, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Republic of, Peru, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
-
ViiV HealthcarePfizerTerminatedHIV-1United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland
-
Gilead SciencesRecruitingHIV-1-infectionJapan, Germany, France, United States, Spain, Korea, Republic of, South Africa, Australia, Argentina, Canada, Dominican Republic, Italy, Puerto Rico, Taiwan, United Kingdom
-
Tibotec Pharmaceuticals, IrelandCompletedHIV-1United States, Belgium, Germany, Taiwan, Spain, Mexico, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Korea, Republic of, Russian Federation, Puerto Rico, Luxembourg
-
Merck Sharp & Dohme LLCRecruitingHIV-1 InfectionUnited States, Israel, Puerto Rico, Japan, South Africa, Chile, Thailand, United Kingdom, Argentina, Colombia, France, Germany, Malaysia, Spain, Switzerland, Guatemala, Turkey, Canada
-
University Hospital, EssenFederal Ministry of Education and Reserach (BMBF)CompletedDetection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...Germany
-
NEAT ID FoundationGilead SciencesCompletedCOVID-19 | HIV-1-infectionSpain, Germany, Netherlands, United Kingdom, France, Belgium, Italy, Greece
-
Merck Sharp & Dohme LLCActive, not recruitingHIV-1 InfectionUnited States, Australia, Canada, Chile, Colombia, France, Germany, Italy, Japan, New Zealand, Poland, Russian Federation, South Africa, Spain, Switzerland, United Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV-1 Infection | Infection, Human Immunodeficiency Virus IGermany, Spain, France, Belgium, United Kingdom, Italy, Romania, Russian Federation, Switzerland